These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12389613)
1. Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia. Schaich M; Illmer T Leuk Lymphoma; 2002 Jul; 43(7):1345-54. PubMed ID: 12389613 [TBL] [Abstract][Full Text] [Related]
2. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia. Schaich M; Ritter M; Illmer T; Lisske P; Thiede C; Schäkel U; Mohr B; Ehninger G; Neubauer A Br J Haematol; 2001 Feb; 112(2):300-7. PubMed ID: 11167822 [TBL] [Abstract][Full Text] [Related]
3. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Leith CP; Chen IM; Kopecky KJ; Appelbaum FR; Head DR; Godwin JE; Weick JK; Willman CL Blood; 1995 Sep; 86(6):2329-42. PubMed ID: 7545025 [TBL] [Abstract][Full Text] [Related]
4. Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias. Nakayama M; Wada M; Harada T; Nagayama J; Kusaba H; Ohshima K; Kozuru M; Komatsu H; Ueda R; Kuwano M Blood; 1998 Dec; 92(11):4296-307. PubMed ID: 9834236 [TBL] [Abstract][Full Text] [Related]
5. MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7. van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; Slater RM; Smit EM; van Noesel MM; van der Holt B; Schoester M; Pieters R; Sonneveld P Leukemia; 2001 Mar; 15(3):398-405. PubMed ID: 11237063 [TBL] [Abstract][Full Text] [Related]
6. MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. van den Heuvel-Eibrink MM; Wiemer EA; de Boevere MJ; van der Holt B; Vossebeld PJ; Pieters R; Sonneveld P Blood; 2001 Jun; 97(11):3605-11. PubMed ID: 11369657 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation. Wang YH; Imai Y; Shiseki M; Tanaka J; Motoji T Leuk Res; 2018 Apr; 67():99-108. PubMed ID: 29482174 [TBL] [Abstract][Full Text] [Related]
8. ras oncogene activation and occupational exposures in acute myeloid leukemia. Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344 [TBL] [Abstract][Full Text] [Related]
9. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia. Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368 [TBL] [Abstract][Full Text] [Related]
10. MDR1/P-GP expression as a prognostic factor in acute leukemias. Marie JP; Legrand O Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774 [TBL] [Abstract][Full Text] [Related]
11. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Goemans BF; Zwaan CM; Miller M; Zimmermann M; Harlow A; Meshinchi S; Loonen AH; Hählen K; Reinhardt D; Creutzig U; Kaspers GJ; Heinrich MC Leukemia; 2005 Sep; 19(9):1536-42. PubMed ID: 16015387 [TBL] [Abstract][Full Text] [Related]
12. Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias. Arai Y; Masuda M; Sugawara I; Arai T; Motoji T; Tsuruo T; Oshimi K; Mizoguchi H Leuk Res; 1997 Apr; 21(4):313-9. PubMed ID: 9150348 [TBL] [Abstract][Full Text] [Related]
13. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway. Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326 [TBL] [Abstract][Full Text] [Related]
14. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). van den Heuvel-Eibrink MM; Wiemer EA; Prins A; Meijerink JP; Vossebeld PJ; van der Holt B; Pieters R; Sonneveld P Leukemia; 2002 May; 16(5):833-9. PubMed ID: 11986944 [TBL] [Abstract][Full Text] [Related]
15. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age. van den Heuvel-Eibrink MM; van der Holt B; Burnett AK; Knauf WU; Fey MF; Verhoef GE; Vellenga E; Ossenkoppele GJ; Löwenberg B; Sonneveld P Ann Hematol; 2007 May; 86(5):329-37. PubMed ID: 17340137 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of cytogenetics and multidrug resistance (MDR1) in elderly patients with acute myeloid leukemia. Stasi R; Del Poeta G; Venditti A; Masi M; Stipa E; Cox MC; Amadori S Blood; 1998 Jul; 92(2):695-7. PubMed ID: 9657773 [No Abstract] [Full Text] [Related]
17. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Chin KV; Ueda K; Pastan I; Gottesman MM Science; 1992 Jan; 255(5043):459-62. PubMed ID: 1346476 [TBL] [Abstract][Full Text] [Related]
18. Methylation analysis of the human multidrug resistance 1 gene in normal and leukemic hematopoietic cells. Fryxell KB; McGee SB; Simoneaux DK; Willman CL; Cornwell MM Leukemia; 1999 Jun; 13(6):910-7. PubMed ID: 10360380 [TBL] [Abstract][Full Text] [Related]
19. Multi-drug resistance (MDR1) gene expression in de novo acute leukemia cells: correlations with CD surface markers and treatment outcome. Jiang EZ; Chang YJ; Lee JW; Lee WK; Kim JS; Sohn SK; Lee KB; Suh JS J Korean Med Sci; 1998 Dec; 13(6):617-22. PubMed ID: 9886170 [TBL] [Abstract][Full Text] [Related]
20. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]